Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,077 public trials 1,842 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Active, Not Recruiting

Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy

NCT03965689

Conditions
Lung Diseases, Lung Neoplasms, Metastatic Lung Non-Small Cell Squamous Carcinoma, +12 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
View Trial Details
Active, Not Recruiting

Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer

NCT03540420

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Aalborg Universitetshospital Aalborg, Denmark
  • Rigshospitalet Copenhagen, Denmark
  • Odense University Hospital Odense, Denmark
  • National Cancer Institute Vilnius, Lithuania
View all 41 locations
View Trial Details
Active, Not Recruiting

A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic Cancer

NCT05215769

Conditions
Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +20 more
Locations
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • St. Rita's Lima, Ohio, United States
  • Saint Francis Medical Center Richmond, Ohio, United States
  • Saint Elizabeth Youngstown Hospital Youngstown, Ohio, United States
View Trial Details
Active, Not Recruiting

Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors

NCT05858736

Conditions
Adenocarcinoma, Adnexal Diseases, Anal Cancer, +85 more
Locations
  • St. Vincent's Private Hospital Darlinghurst, New South Wales, Australia
  • Mater Misericordiae Ltd. Brisbane, Queensland, Australia
  • Tasman Oncology Research Southport, Queensland, Australia
  • Cancer Research SA Adelaide, South Australia, Australia
View Trial Details
Active, Not Recruiting

Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion

NCT04794699

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lung Diseases, +14 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • Rockefeller Cancer Institute Little Rock, Arkansas, United States
  • City of Hope Duarte, California, United States
  • Orlando Health Cancer Institute Orlando, Florida, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

A Study of Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11)

NCT06099782

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +32 more
Locations
  • Russell Medical ( Site 0160) Alexander City, Alabama, United States
  • Alaska Oncology and Hematology ( Site 0121) Anchorage, Alaska, United States
  • Highlands Oncology Group-Research Department ( Site 0133) Springdale, Arkansas, United States
  • Marin Cancer Care ( Site 0148) Greenbrae, California, United States
View all 45 locations
View Trial Details
Active, Not Recruiting

ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)

NCT04044859

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +54 more
Locations
  • Name of Institution: Orlando Health Cancer Institute Orlando, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University - School of Medicine St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View all 17 locations
View Trial Details

Related conditions